首页> 外文期刊>American Journal of Biomedical and Life Sciences >Paraoxonase-1 and Glutathione Peroxidase Activity as a Screening Tool in Detecting Severity of Coronary Artery Disease: Case Control Feasibility Study
【24h】

Paraoxonase-1 and Glutathione Peroxidase Activity as a Screening Tool in Detecting Severity of Coronary Artery Disease: Case Control Feasibility Study

机译:对氧磷酶-1和谷胱甘肽过氧化物酶活性作为检测冠状动脉疾病严重程度的筛选工具:病例对照可行性研究

获取原文
           

摘要

Glutathione peroxidase and paraoxonase-1 is reported to be a useful marker for monitoring cardiovascular disease. Due to the paucity of information on the association of above markers and severity of coronary artery disease in South Asian patients, case control study was performed with 85 patients (58 males and 27 females) 40-60 years of age confirmed as having coronary artery disease on coronary angiography findings and 85 age and sex matched healthy volunteers as controls. Blood samples were analyzed for serum paraoxonase-1 and erythrocyte Glutathione peroxidase activity in both groups and the severity of coronary artery disease was assessed using coronary angiographic scoring system based on vessel, stenosis and extent score. Patients with coronary artery disease showed significantly low paraoxonase-1 and Glutathione peroxidase activity compared to control subjects. However, according to the best cutoff value determined by receiver operating characteristic analysis for serum paraoxonase-1 (38μg/mL) did not show a significantly high sensitivity, negative predictive value and negative likelihood ratio when compared to erythrocyte Glutathione peroxidase (84.5U/gHb) in predicting the severity of coronary artery disease assessed by three angiographic scores. Glutathione peroxidase appears to be an accurate marker in ruling out major coronary vessel disease and luminal narrowing by atheroma.
机译:据报道谷胱甘肽过氧化物酶和对氧磷酶-1是监测心血管疾病的有用标记。由于在南亚患者中缺乏上述标志物与冠状动脉疾病严重程度之间的联系的信息,病例对照研究针对40至60岁的确诊为冠心病的85例患者(男58例,女27例)进行了病例对照研究冠状动脉造影检查结果和85位年龄和性别相匹配的健康志愿者作为对照。分析两组患者的血样中血清对氧磷酶-1和红细胞谷胱甘肽过氧化物酶活性,并使用冠状动脉血管造影评分系统根据血管,狭窄和程度评分评估冠状动脉疾病的严重程度。与对照组相比,冠心病患者的对氧磷酶-1和谷胱甘肽过氧化物酶活性明显降低。但是,根据接受者操作特性分析确定的最佳临界值,血清对氧磷酶-1(38μg/ mL)与红细胞谷胱甘肽过氧化物酶(84.5U / gHb)相比,没有显示出明显的高灵敏度,阴性预测值和阴性似然比。 )通过三个血管造影评分评估冠状动脉疾病的严重程度。谷胱甘肽过氧化物酶似乎是排除主要冠状动脉疾病和动脉粥样硬化引起的管腔狭窄的准确标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号